Net sales increased 116.0 percent to SEK 10.8 million (5.0).
The operating result was SEK -9.2 million (-15.3).
Profit before tax was SEK -10.2 million (-16.7).
The result after tax was SEK -10.2 million (-16.8).
Earnings per share amounted to SEK -0.12 (-0.46).
Cash flow from operating activities amounted to SEK -19.2 million (-8.7) in the first quarter.
Cash and cash equivalents amounted to SEK 23.3 million (23.6) as of March 31. Shortly after the end of the quarter, the company's cash and cash equivalents increased by SEK 7 million as a result of incoming payment from a customer.
"The first quarter of the year was a sales record for a single quarter for the company and a good start to the new year. The positive customer dialogues being conducted in combination with continued stabilization of the production process create good conditions for increased sales growth during the year," the company writes in the interim report.
- "In summary, we are confident that we will deliver growth during the year, while it is likely that sales will vary from quarter to quarter," comments CEO Andreas Bhagwani in the interim report.
Nanologica expects strong sales growth in the second half of the year.
- Despite a shaky business environment, I am optimistic about Nanologica's development in 2025. The combination of strong global demand and the fact that we are rebuilding and expanding production means that I expect strong sales growth in the second half of the year. I look forward to reporting further progress during the rest of the year," concludes Andreas Bhagwani.
| Nanologica, SEKm | Q1-2025 | Q1-2024 | Change in |
| Net sales | 10,8 | 5,0 | 116,0% |
| Operating profit/loss | -9,2 | -15,3 | |
| Profit before tax | -10,2 | -16,7 | |
| Net result | -10,2 | -16,8 | |
| Earnings per share, SEK | -0,12 | -0,46 | |
| Cash flow from operating activities | -19,2 | -8,7 | |
| Cash and cash equivalents | 23,3 | 23,6 | -1,3% |
